StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer DB Segment — Biopharma Segment Revenues by Quarter

DB Segment — Biopharma Segment Revenues ($M) ($M)

QuarterlyAnnual

Pfizer DB Segment — Biopharma Segment Revenues: $14,661M in Q2 2026, up 2.5% from a year earlier.

Latest, Q2 2026
14,661
Period ended Jun 28, 2026
Change on a year earlier
+2.5%
14,305 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
21
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Database (SEC Form 10-K / 10-Q XBRL via lib/db.py).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDB Segment — Biopharma Segment Revenues ($M) ($M)Year on yearSource
Q2 2026Jun 28, 202614,661+2.5%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 29, 202614,161+5.4%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 202517,143-1.6%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 28, 202516,310-6.2%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 29, 202514,305+10.1%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 30, 202513,441-8.0%Form 10-Q (filed 2025-05-05) ↗
Q4 2024Dec 31, 202417,413+22.7%Form 10-K (filed 2025-02-27) ↗
Q3 2024Sep 29, 202417,392+31.9%Form 10-Q (filed 2024-11-04) ↗
Q2 2024Jun 30, 202412,991+2.4%Form 10-Q (filed 2024-08-05) ↗
Q1 2024Mar 31, 202414,604-19.6%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 202314,186-42.7%Form 10-K (filed 2025-02-27) ↗
Q3 2023Oct 1, 202313,188-40.9%Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jul 2, 202312,690-53.7%Form 10-Q (filed 2024-08-05) ↗
Q1 2023Apr 2, 202318,173-28.2%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 202224,760+5.6%Form 10-K (filed 2025-02-27) ↗
Q3 2022Oct 2, 202222,319-5.1%Form 10-Q (filed 2022-11-09) ↗

Breakdown

What makes up DB Segment — Biopharma Segment Revenues

Cite this data

StockData. (2026). Pfizer DB Segment — Biopharma Segment Revenues ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-seg-rev-bio

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.